Alterations opioid parameters hypothalamus rats estradiol-induced polycystic ovarian disease distribution density mu- delta- kappa-opioid binding sites vitro radioautography hypothalamus normal estradiol valerate EV estradiol female rats Hypothalamic beta-endorphin concentration RIA groups animals Quantitative analysis film radioautographs selective increase mu-opioid binding medial preoptic area EV-treated rats groups reduction density delta-opioid binding suprachiasmatic nucleus Statistically significant changes groups kappa-opioid binding Results hypothalamic concentration beta-endorphin marked reduction EV-injected animals respect controls contrast animals beta-endorphin concentrations similar controls present results increase opioid receptor hypothalamus EV-treated rats demonstrate increase medial preoptic area concerns mu-opioid receptors concomitant reduction beta-endorphin levels group animals observed increase mu-opioid binding chronic up-regulation receptor response beta-endorphin input restriction effect site origin LHRH neurons demonstrated inhibitory role opioids LHRH release up-regulation suppression plasma LH pattern polycystic ovarian disease EV-treated rat 